Zobrazeno 1 - 10
of 84
pro vyhledávání: '"John H. Mcdermott"'
Publikováno v:
Clocks & Sleep, Vol 6, Iss 1, Pp 11-23 (2023)
Background: Day-to-day variations in sleep timing have been associated with poorer glycemic control in type 2 diabetes mellitus, although the factors that influence this sleep timing variability are poorly understood. Methods: Daily routines of sleep
Externí odkaz:
https://doaj.org/article/98a4cf3ef1dc4f04866c43e2aa2c6278
Publikováno v:
Clocks & Sleep, Vol 4, Iss 4, Pp 658-674 (2022)
Variability in the timing of daily sleep is increasingly recognized as an important factor in sleep and general physical health. One potential driver of such daily variations in sleep timing is different work and social obligations during the “work
Externí odkaz:
https://doaj.org/article/60c59020244d4874a6d88e39d230aac6
Autor:
John H. McDermott, Stuart Wright, Videha Sharma, William G. Newman, Katherine Payne, Paul Wilson
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Several healthcare organizations have developed pre-emptive pharmacogenetic testing programs, where testing is undertaken prior to the prescription of a medicine. This review characterizes the barriers and facilitators which influenced the developmen
Externí odkaz:
https://doaj.org/article/3b1efa8fe9c74ad08f55d7f1691342b9
Autor:
Khaled Aljenaee, Osamah Hakami, Colin Davenport, Gemma Farrell, Tommy Kyaw Tun, Agnieszka Pazderska, Niamh Phelan, Marie-Louise Healy, Seamus Sreenan, John H McDermott
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2019)
Measurement of glycated haemoglobin (HbA1c) has been utilised in assessing long-term control of blood glucose in patients with diabetes, as well as diagnosing diabetes and identifying patients at increased risk of developing diabetes in the future. H
Externí odkaz:
https://doaj.org/article/242519a12a0943ffa8dc4062806f1eb4
Autor:
Osamah A Hakami, Julia Ioana, Shahzad Ahmad, Tommy Kyaw Tun, Seamus Sreenan, John H McDermott
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-4 (2019)
Immune checkpoint inhibitors (ICIs) have revolutionised cancer therapy and improved outcomes for patients with advanced disease. Pembrolizumab, a monoclonal antibody that acts as a programmed cell death 1 (PD-1(PDCD1)) inhibitor, has been approved fo
Externí odkaz:
https://doaj.org/article/f1ddf987aa19450fa4077f8c717dd969
Autor:
Jamie M Ellingford, Ryan George, John H McDermott, Shazaad Ahmad, Jonathan J Edgerley, David Gokhale, William G Newman, Stephen Ball, Nicholas Machin, Graeme CM Black
Publikováno v:
eLife, Vol 10 (2021)
Understanding the effectiveness of infection control methods in reducing and preventing SARS-CoV-2 transmission in healthcare settings is of high importance. We sequenced SARS-CoV-2 genomes for patients and healthcare workers (HCWs) across multiple g
Externí odkaz:
https://doaj.org/article/ccd0a2e9674f422e9315dcf5926a5603
Autor:
Khaled Aljenaee, Sulaiman Ali, Seong Keat Cheah, Owen MacEneaney, Niall Mulligan, Neil Hickey, Tommy Kyaw Tun, Seamus Sreenan, John H McDermott
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2017)
Markedly elevated androgen levels can lead to clinical virilization in females. Clinical features of virilization in a female patient, in association with biochemical hyperandrogenism, should prompt a search for an androgen-producing tumor, especiall
Externí odkaz:
https://doaj.org/article/bb3a3af56e1941eca17c3d8bf34848d1
Autor:
John H McDermott, Marc Leach, Dwaipayan Sen, Craig J. Smith, William G. Newman, Philip M. Bath
Publikováno v:
Expert Review of Clinical Pharmacology. 15:811-825
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16a3831fa093b20ee6741b32ff5212e9
https://doi.org/10.1080/17512433.2022.2108401
https://doi.org/10.1080/17512433.2022.2108401
Autor:
Videha Sharma, John H McDermott, Jessica Keen, Simon Foster, Pauline Whelan, William G Newman
UNSTRUCTURED Pharmacogenetics has been shown to impact patient care and outcomes through personalising the selection of medicines resulting in improved efficacy and a reduction in harmful side effects. Despite compelling clinical evidence and interna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea4a1ef256dd7fb6d30184bb26b99b0f
https://doi.org/10.2196/preprints.49230
https://doi.org/10.2196/preprints.49230
This article identifies issues relating to the use of genetics and genomics in insurance that may challenge existing regulatory models in the UK and elsewhere. We discuss three core issues: (1) As genomic testing advances, and results are increasingl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e5439a23027d96fb989272c31abfebf
https://doi.org/10.31235/osf.io/p3hsy
https://doi.org/10.31235/osf.io/p3hsy